77 related articles for article (PubMed ID: 25778661)
41. Smooth muscle-like tissues engineered with bone marrow stromal cells.
Cho SW; Kim IK; Lim SH; Kim DI; Kang SW; Kim SH; Kim YH; Lee EY; Choi CY; Kim BS
Biomaterials; 2004 Jul; 25(15):2979-86. PubMed ID: 14967530
[TBL] [Abstract][Full Text] [Related]
42. [Differentiation of hematopoietic and stromal elements of extramedullary bone marrow transplants in irradiated recipients].
Starostin VI; Sludskaia AI
Ontogenez; 1974; 5(5):518-20. PubMed ID: 4620022
[TBL] [Abstract][Full Text] [Related]
43. [Hematopoietic stroma and the regulation of hematopoiesis in extramedullary bone marrow transplants in mice].
Starostin VI; Satdykova GP; Derevianko VP
Ontogenez; 1982; 13(6):572-81. PubMed ID: 6760027
[TBL] [Abstract][Full Text] [Related]
44. [Marrow stromal cells and repair of bone defect].
Peng S; Fang H; Luo Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2005 Mar; 19(3):245-8. PubMed ID: 15828486
[TBL] [Abstract][Full Text] [Related]
45. Origination of stromal precursor cells replenishing the population of these cells in heterotopic mouse bone marrow transplants after curettage in recipients.
Gorskaya YF; Nesterenko VG; Domracheva EV; Aseeva EA; Timofeeva NM
Bull Exp Biol Med; 2007 May; 143(5):630-3. PubMed ID: 18239788
[TBL] [Abstract][Full Text] [Related]
46. In vitro growth and hemopoietic differentiation of mouse bone marrow-derived adherent stromal cells in long-term culture: formation of spheroidal bodies mimicking hemopoietic anlagen.
Islam A; Bielat KL; Glomski C; Henderson ES
J Med; 1989; 20(3-4):193-207. PubMed ID: 2809419
[TBL] [Abstract][Full Text] [Related]
47. Properties of chitosan-collagen sponges and osteogenic differentiation of rat-bone-marrow stromal cells.
Arpornmaeklong P; Pripatnanont P; Suwatwirote N
Int J Oral Maxillofac Surg; 2008 Apr; 37(4):357-66. PubMed ID: 18272341
[TBL] [Abstract][Full Text] [Related]
48. [Stromal bone marrow cells and the hematopoietic microenvironment].
Fridenshteĭn AIa
Arkh Patol; 1982; 44(10):3-11. PubMed ID: 7181706
[TBL] [Abstract][Full Text] [Related]
49. Bone grafts cultured with bone marrow stromal cells for the repair of critical bone defects: an experimental study in mice.
Dumas A; Moreau MF; Ghérardi RK; Baslé MF; Chappard D
J Biomed Mater Res A; 2009 Sep; 90(4):1218-29. PubMed ID: 18683231
[TBL] [Abstract][Full Text] [Related]
50. Influence of the in vitro culture period on the in vivo performance of cell/titanium bone tissue-engineered constructs using a rat cranial critical size defect model.
Sikavitsas VI; van den Dolder J; Bancroft GN; Jansen JA; Mikos AG
J Biomed Mater Res A; 2003 Dec; 67(3):944-51. PubMed ID: 14613243
[TBL] [Abstract][Full Text] [Related]
51. Chitosan-poly(butylene succinate) scaffolds and human bone marrow stromal cells induce bone repair in a mouse calvaria model.
Costa-Pinto AR; Correlo VM; Sol PC; Bhattacharya M; Srouji S; Livne E; Reis RL; Neves NM
J Tissue Eng Regen Med; 2012 Jan; 6(1):21-8. PubMed ID: 21312336
[TBL] [Abstract][Full Text] [Related]
52. Hemopoietic stromal precursors in long-term culture of bone marrow: I. Precursor characteristics, kinetics in culture, and dependence on quality of donor hemopoietic cells in chimeras.
Chertkov JL; Drize NJ; Gurevitch OA; Udalov GA
Exp Hematol; 1983 Mar; 11(3):231-42. PubMed ID: 6131832
[TBL] [Abstract][Full Text] [Related]
53. Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1.
Abraham NG; Chertkov JL; Staudinger R; Jiang S; Lutton JD; Argani I; Levere RD; Kappas A
Exp Hematol; 1993 Feb; 21(2):263-8. PubMed ID: 7678812
[TBL] [Abstract][Full Text] [Related]
54. Anabolic actions of PTH (1-34): use of a novel tissue engineering model to investigate temporal effects on bone.
Pettway GJ; Schneider A; Koh AJ; Widjaja E; Morris MD; Meganck JA; Goldstein SA; McCauley LK
Bone; 2005 Jun; 36(6):959-70. PubMed ID: 15878317
[TBL] [Abstract][Full Text] [Related]
55. Maxillary sinus floor elevation using a tissue-engineered bone complex with OsteoBone and bMSCs in rabbits.
Sun XJ; Zhang ZY; Wang SY; Gittens SA; Jiang XQ; Chou LL
Clin Oral Implants Res; 2008 Aug; 19(8):804-13. PubMed ID: 18705812
[TBL] [Abstract][Full Text] [Related]
56. [Origin of hematopoietic cells in a syngenous and semisyngenous focus of heterotopic hematopoiesis].
Udalov GA; Gurevich OA; Chertkov IL
Biull Eksp Biol Med; 1977 May; 83(5):584-6. PubMed ID: 328078
[TBL] [Abstract][Full Text] [Related]
57. Ovine bone- and marrow-derived progenitor cells and their potential for scaffold-based bone tissue engineering applications in vitro and in vivo.
Reichert JC; Woodruff MA; Friis T; Quent VM; Gronthos S; Duda GN; Schütz MA; Hutmacher DW
J Tissue Eng Regen Med; 2010 Oct; 4(7):565-76. PubMed ID: 20568083
[TBL] [Abstract][Full Text] [Related]
58. Autologous bone marrow stromal cells loaded onto porous gelatin scaffolds containing Drynaria fortunei extract for bone repair.
Chen KY; Dong GC; Hsu CY; Chen YS; Yao CH
J Biomed Mater Res A; 2013 Apr; 101(4):954-62. PubMed ID: 22965916
[TBL] [Abstract][Full Text] [Related]
59. Effect of Activated Immunocompetent Cells on the Content of Multipotent Stromal Cells in Splenic Transplants of CBA and CBA/N Mice Administered with Polyvinylpyrrolidone.
Gorskaya YF; Tukhvatulin AI; Dzharullaeva AS; Semenova EN; Vavilova LM; Nagurskaya EV; Bekhalo VA; Nesterenko VG
Bull Exp Biol Med; 2023 May; 175(1):67-71. PubMed ID: 37338771
[TBL] [Abstract][Full Text] [Related]
60. Leading centers for low-dose bone marrow transplants.
Vastag B
J Natl Cancer Inst; 2000 Aug; 92(16):1285. PubMed ID: 10944542
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
